title: A fatal case of hepatitis C seroconversion following living related kidney transplantation: another argument for nucleic acid amplification testing of transplant recipients and donors.
authors.forename: Steven M
authors.initials: SM
authors.lastname: Gordon
authors.forename: W
authors.initials: W
authors.lastname: Carey
authors.forename: B
authors.initials: B
authors.lastname: Yen-Lieberman
authors.forename: V
authors.initials: V
authors.lastname: Dennis
authors.forename: S
authors.initials: S
authors.lastname: Nurko
authors.forename: G
authors.initials: G
authors.lastname: Hoeltge
authors.forename: D
authors.initials: D
authors.lastname: Goldfarb
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D017809:Fatal Outcome; D005260:Female; D016174:Hepacivirus / Q000235:genetics / Q000302:isolation & purification / Q000502:physiology*; D006526:Hepatitis C / Q000188:drug therapy / Q000276:immunology*; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D019520:Living Donors; D012328:RNA Viruses / Q000302:isolation & purification; D014766:Viremia / Q000188:drug therapy / Q000821:virology
chemical_list: D000998:Antiviral Agents